HCR Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $379K | Sell |
2,999
-62
| -2% | -$7.85K | 0.04% | 167 |
|
|
2025
Q1 | $392K | Hold |
3,061
| – | – | 0.05% | 163 |
|
|
2024
Q4 | $405K | Sell |
3,061
-7,645
| -71% | -$1.01M | 0.05% | 158 |
|
|
2024
Q3 | $1.56M | Sell |
10,706
-2,747
| -20% | -$400K | 0.2% | 76 |
|
|
2024
Q2 | $1.85M | Buy |
13,453
+83
| +0.6% | +$11.4K | 0.26% | 60 |
|
|
2024
Q1 | $1.83M | Sell |
13,370
-724
| -5% | -$99.3K | 0.28% | 62 |
|
|
2023
Q4 | $1.91M | Sell |
14,094
-803
| -5% | -$109K | 0.3% | 57 |
|
|
2023
Q3 | $1.82M | Sell |
14,897
-5,377
| -27% | -$658K | 0.4% | 46 |
|
|
2023
Q2 | $2.57M | Buy |
20,274
+14,624
| +259% | +$1.86M | 0.48% | 36 |
|
|
2023
Q1 | $730K | Sell |
5,650
-200
| -3% | -$25.8K | 0.14% | 91 |
|
|
2022
Q4 | $768K | Sell |
5,850
-133
| -2% | -$17.5K | 0.16% | 89 |
|
|
2022
Q3 | $700K | Sell |
5,983
-570
| -9% | -$66.7K | 0.15% | 92 |
|
|
2022
Q2 | $771K | Sell |
6,553
-2,535
| -28% | -$298K | 0.15% | 92 |
|
|
2022
Q1 | $1.18M | Sell |
9,088
-29,426
| -76% | -$3.83M | 0.19% | 82 |
|
|
2021
Q4 | $5.88M | Buy |
38,514
+278
| +0.7% | +$42.4K | 0.91% | 19 |
|
|
2021
Q3 | $6.18M | Buy |
38,236
+181
| +0.5% | +$29.3K | 1.03% | 17 |
|
|
2021
Q2 | $6.23M | Buy |
38,055
+811
| +2% | +$133K | 1.08% | 16 |
|
|
2021
Q1 | $5.61M | Sell |
37,244
-560
| -1% | -$84.3K | 1.11% | 15 |
|
|
2020
Q4 | $5.73M | Buy |
37,804
+2,041
| +6% | +$309K | 1.2% | 13 |
|
|
2020
Q3 | $4.84M | Buy |
35,763
+32,909
| +1,153% | +$4.46M | 1.11% | 14 |
|
|
2020
Q2 | $392K | Buy |
2,854
+1,724
| +153% | +$237K | 0.09% | 108 |
|
|
2020
Q1 | $122K | Buy |
1,130
+50
| +5% | +$5.4K | 0.03% | 153 |
|
|
2019
Q4 | $130K | Buy |
+1,080
| New | +$130K | 0.03% | 162 |
|
|
2019
Q1 | – | Sell |
-6,503
| Closed | -$627K | – | 183 |
|
|
2018
Q4 | $627K | Sell |
6,503
-49
| -0.7% | -$4.72K | 0.2% | 87 |
|
|
2018
Q3 | $729K | Sell |
6,552
-521
| -7% | -$58K | 0.24% | 83 |
|
|
2018
Q2 | $785K | Sell |
7,073
-800
| -10% | -$88.8K | 0.26% | 85 |
|
|
2018
Q1 | $840K | Sell |
7,873
-200
| -2% | -$21.3K | 0.29% | 83 |
|
|
2017
Q4 | $862K | Buy |
8,073
+60
| +0.7% | +$6.41K | 0.3% | 75 |
|
|
2017
Q3 | $891K | Buy |
8,013
+780
| +11% | +$86.7K | 0.38% | 68 |
|
|
2017
Q2 | $748K | Buy |
7,233
+1,830
| +34% | +$189K | 0.37% | 65 |
|
|
2017
Q1 | $528K | Sell |
5,403
-180
| -3% | -$17.6K | 0.27% | 83 |
|
|
2016
Q4 | $494K | Buy |
+5,583
| New | +$494K | 0.26% | 88 |
|